Milind Vasudev

University of California, Irvine

Papers

1

Total Citations

3

H-Index

1

About

Milind Vasudev is a rising surgical oncologist whose research centers on head and neck cancer, with a particular focus on oropharyngeal squamous cell carcinoma (OPSCC) and the interplay between human papillomavirus (HPV) status and treatment outcomes. His most cited work, a 2024 study published in a leading otolaryngology journal, leverages the National Cancer Database to investigate how treatment delay impacts survival in HPV-positive versus HPV-negative OPSCC patients undergoing upfront surgery. This retrospective cohort analysis, already garnering 3 citations in its first year, provides critical, evidence-based insights into optimizing surgical timing for distinct patient subgroups. Vasudev’s contribution lies in clarifying a nuanced clinical dilemma: while HPV-positive patients generally have better prognoses, his work suggests that delays may disproportionately affect outcomes, challenging one-size-fits-all treatment paradigms. By dissecting a large, real-world dataset, he offers actionable guidance for multidisciplinary care teams. His research underscores a commitment to precision oncology, bridging epidemiology and surgical decision-making. As an emerging voice in head and neck oncology, Vasudev’s work is poised to influence national treatment guidelines and improve survival stratification for diverse patient populations.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Treatment Delay and HPV Status on OPSCC With Upfront Surgery: Analysis of National Cancer Database
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of California, Irvine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago